Liver transplant trial for colon cancer patients pulled before it started

NCT ID NCT05175092

Terminated Disease control Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study planned to test whether a living donor liver transplant, after standard chemotherapy, could help people with colorectal cancer that spread to the liver and could not be surgically removed. It aimed to enroll 25 donor-recipient pairs. However, the study was withdrawn before any participants were enrolled, so no data was collected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Living donor liver transplant (procedure)
What this could lead to: If successful, this approach could offer a way to treat colorectal cancer that has spread to the liver and cannot be removed by surgery.
What could go wrong: The study was withdrawn before any participants were enrolled, so no results are available. Liver transplant carries major risks, and lifelong anti-rejection medication is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastasis from malignant tumor of colon

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER METASTASIS COLON CANCER

Contacts and locations

Locations

University of Wisconsin School of Medicine and Public Health

Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.